{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4556"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4556","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"HYBRID LIPID-GOLD NANOPARTICLES DESIGNED FOR SIMULTANEOUS GENE THERAPY AND PHOTOTHERMAL THERAPY AGAINST CANCER","abstract":"Traditional cancer treatments such as chemotherapy and surgery include adverse side effects and acquire resistance. Here, I developed a novel hybrid lipid-gold nanoparticle technology (LGNP) to achieve simultaneous gene regulation and photothermal therapy, specifically targeting pediatric acute myeloid leukemia (AML) and ovarian cancer. This core material consists of slice core/gold nanoshells, which are efficient heat transducers where NIR light activates nanoshells embedded in tumors, generating localized heat for tumor ablation. The ionizable lipid coating facilitates intracellular delivery of nucleic acids, such as mRNA or siRNA, to modulate gene expression effectively. Lipid-gold hybrid nanoparticles (LGNPs) are synthesized via a controlled self-assembly process, incorporating a lipid layer with polyethylene glycol (PEG) linkers. We optimized LGNP formulations by varying PEG molar ratios to enhance mRNA delivery by evaluating LGNP uptake and transfection in Kasumi-1 (pediatric AML) and OVCAR-3 (ovarian cancer) cell lines. Further, LGNPs facilitated efficient mRNA delivery, yielding a 700-fold increase in luminescence in Kasumi-1 AML cells and a 6000-fold increase in OVCAR-3 ovarian cancer cells compared to controls.","abstract_html":"Traditional cancer treatments such as chemotherapy and surgery include adverse side effects and acquire resistance. Here, I developed a novel hybrid lipid-gold nanoparticle technology (LGNP) to achieve simultaneous gene regulation and photothermal therapy, specifically targeting pediatric acute myeloid leukemia (AML) and ovarian cancer. This core material consists of slice core/gold nanoshells, which are efficient heat transducers where NIR light activates nanoshells embedded in tumors, generating localized heat for tumor ablation. The ionizable lipid coating facilitates intracellular delivery of nucleic acids, such as mRNA or siRNA, to modulate gene expression effectively. Lipid-gold hybrid nanoparticles (LGNPs) are synthesized via a controlled self-assembly process, incorporating a lipid layer with polyethylene glycol (PEG) linkers. We optimized LGNP formulations by varying PEG molar ratios to enhance mRNA delivery by evaluating LGNP uptake and transfection in Kasumi-1 (pediatric AML) and OVCAR-3 (ovarian cancer) cell lines. Further, LGNPs facilitated efficient mRNA delivery, yielding a 700-fold increase in luminescence in Kasumi-1 AML cells and a 6000-fold increase in OVCAR-3 ovarian cancer cells compared to controls.","abstract_has_math":false,"creators":["Devaguptapu, Navya sree"],"institution":null,"degree_name":"M.S. Biomedical Engineering","degree_level":"Thesis","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":["Rachel Riley, Ph.D.","Vincent Beachley, Ph.D.","Erik Brewer, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:00:08Z","subjects":["Cancer therapy;drug delivery;Gene therapy;lipid-gold nanoparticles;Nanoparticles;photothermal therapy"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3550","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3550","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4556","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Rachel Riley, Ph.D.","Vincent Beachley, Ph.D.","Erik Brewer, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Devaguptapu, Navya sree"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-07-06T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2026-07-06T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S. Biomedical Engineering"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cancer therapy;drug delivery;Gene therapy;lipid-gold nanoparticles;Nanoparticles;photothermal therapy"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3550"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Traditional cancer treatments such as chemotherapy and surgery include adverse side effects and acquire resistance. Here, I developed a novel hybrid lipid-gold nanoparticle technology (LGNP) to achieve simultaneous gene regulation and photothermal therapy, specifically targeting pediatric acute myeloid leukemia (AML) and ovarian cancer. This core material consists of slice core/gold nanoshells, which are efficient heat transducers where NIR light activates nanoshells embedded in tumors, generating localized heat for tumor ablation. The ionizable lipid coating facilitates intracellular delivery of nucleic acids, such as mRNA or siRNA, to modulate gene expression effectively. Lipid-gold hybrid nanoparticles (LGNPs) are synthesized via a controlled self-assembly process, incorporating a lipid layer with polyethylene glycol (PEG) linkers. We optimized LGNP formulations by varying PEG molar ratios to enhance mRNA delivery by evaluating LGNP uptake and transfection in Kasumi-1 (pediatric AML) and OVCAR-3 (ovarian cancer) cell lines. Further, LGNPs facilitated efficient mRNA delivery, yielding a 700-fold increase in luminescence in Kasumi-1 AML cells and a 6000-fold increase in OVCAR-3 ovarian cancer cells compared to controls."]},{"key":"dc:title","label":"Title","values":["HYBRID LIPID-GOLD NANOPARTICLES DESIGNED FOR SIMULTANEOUS GENE THERAPY AND PHOTOTHERMAL THERAPY AGAINST CANCER"]}]}],"canonical_facts":{"dc:contributor":["Rachel Riley, Ph.D.","Vincent Beachley, Ph.D.","Erik Brewer, Ph.D."],"dc:creator":["Devaguptapu, Navya sree"],"dc:date.available":["2026-07-06T07:00:00Z"],"dc:date.created":["2026-07-06T07:00:00Z"],"dc:description.abstract":["Traditional cancer treatments such as chemotherapy and surgery include adverse side effects and acquire resistance. Here, I developed a novel hybrid lipid-gold nanoparticle technology (LGNP) to achieve simultaneous gene regulation and photothermal therapy, specifically targeting pediatric acute myeloid leukemia (AML) and ovarian cancer. This core material consists of slice core/gold nanoshells, which are efficient heat transducers where NIR light activates nanoshells embedded in tumors, generating localized heat for tumor ablation. The ionizable lipid coating facilitates intracellular delivery of nucleic acids, such as mRNA or siRNA, to modulate gene expression effectively. Lipid-gold hybrid nanoparticles (LGNPs) are synthesized via a controlled self-assembly process, incorporating a lipid layer with polyethylene glycol (PEG) linkers. We optimized LGNP formulations by varying PEG molar ratios to enhance mRNA delivery by evaluating LGNP uptake and transfection in Kasumi-1 (pediatric AML) and OVCAR-3 (ovarian cancer) cell lines. Further, LGNPs facilitated efficient mRNA delivery, yielding a 700-fold increase in luminescence in Kasumi-1 AML cells and a 6000-fold increase in OVCAR-3 ovarian cancer cells compared to controls."],"dc:identifier":["https://rdw.rowan.edu/etd/3550"],"dc:subject":["Cancer therapy;drug delivery;Gene therapy;lipid-gold nanoparticles;Nanoparticles;photothermal therapy"],"dc:title":["HYBRID LIPID-GOLD NANOPARTICLES DESIGNED FOR SIMULTANEOUS GENE THERAPY AND PHOTOTHERMAL THERAPY AGAINST CANCER"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S. Biomedical Engineering"]},"updated_at":"2026-11-19T09:00:08Z"}